Hyaluronic acid-coated mannan-conjugated MnO2 particles (Man-HA-MnO2) treatment of a breast tumor mouse model has been shown to significantly increase tumor oxygenation and downregulation of HIF-1α and VEGF in the tumor [178]. The gene discussed is VEGFA; the disease is neoplasm.